312 related articles for article (PubMed ID: 25384509)
1. Identification of OLIG2 as the most specific glioblastoma stem cell marker starting from comparative analysis of data from similar DNA chip microarray platforms.
Trépant AL; Bouchart C; Rorive S; Sauvage S; Decaestecker C; Demetter P; Salmon I
Tumour Biol; 2015 Mar; 36(3):1943-53. PubMed ID: 25384509
[TBL] [Abstract][Full Text] [Related]
2. Expression of CD133 and CD44 in glioblastoma stem cells correlates with cell proliferation, phenotype stability and intra-tumor heterogeneity.
Brown DV; Filiz G; Daniel PM; Hollande F; Dworkin S; Amiridis S; Kountouri N; Ng W; Morokoff AP; Mantamadiotis T
PLoS One; 2017; 12(2):e0172791. PubMed ID: 28241049
[TBL] [Abstract][Full Text] [Related]
3. Combined expressional analysis, bioinformatics and targeted proteomics identify new potential therapeutic targets in glioblastoma stem cells.
Stangeland B; Mughal AA; Grieg Z; Sandberg CJ; Joel M; Nygård S; Meling T; Murrell W; Vik Mo EO; Langmoen IA
Oncotarget; 2015 Sep; 6(28):26192-215. PubMed ID: 26295306
[TBL] [Abstract][Full Text] [Related]
4. Myelin-forming cell-specific cadherin-19 is a marker for minimally infiltrative glioblastoma stem-like cells.
Zorniak M; Clark PA; Kuo JS
J Neurosurg; 2015 Jan; 122(1):69-77. PubMed ID: 25361488
[TBL] [Abstract][Full Text] [Related]
5. LGR5 is a proneural factor and is regulated by OLIG2 in glioma stem-like cells.
Mao XG; Song SJ; Xue XY; Yan M; Wang L; Lin W; Guo G; Zhang X
Cell Mol Neurobiol; 2013 Aug; 33(6):851-65. PubMed ID: 23793848
[TBL] [Abstract][Full Text] [Related]
6. LGR5 promotes tumorigenicity and invasion of glioblastoma stem-like cells and is a potential therapeutic target for a subset of glioblastoma patients.
Xie Y; Sundström A; Maturi NP; Tan EJ; Marinescu VD; Jarvius M; Tirfing M; Jin C; Chen L; Essand M; Swartling FJ; Nelander S; Jiang Y; Uhrbom L
J Pathol; 2019 Feb; 247(2):228-240. PubMed ID: 30357839
[TBL] [Abstract][Full Text] [Related]
7. Atracurium Besylate and other neuromuscular blocking agents promote astroglial differentiation and deplete glioblastoma stem cells.
Spina R; Voss DM; Asnaghi L; Sloan A; Bar EE
Oncotarget; 2016 Jan; 7(1):459-72. PubMed ID: 26575950
[TBL] [Abstract][Full Text] [Related]
8. Maintenance of primary tumor phenotype and genotype in glioblastoma stem cells.
Wakimoto H; Mohapatra G; Kanai R; Curry WT; Yip S; Nitta M; Patel AP; Barnard ZR; Stemmer-Rachamimov AO; Louis DN; Martuza RL; Rabkin SD
Neuro Oncol; 2012 Feb; 14(2):132-44. PubMed ID: 22067563
[TBL] [Abstract][Full Text] [Related]
9. Prognostic impact of glioblastoma stem cell markers OLIG2 and CCND2.
Bouchart C; Trépant AL; Hein M; Van Gestel D; Demetter P
Cancer Med; 2020 Feb; 9(3):1069-1078. PubMed ID: 31568682
[TBL] [Abstract][Full Text] [Related]
10. Targeting glioblastoma stem cells: cell surface markers.
He J; Liu Y; Lubman DM
Curr Med Chem; 2012; 19(35):6050-5. PubMed ID: 22963566
[TBL] [Abstract][Full Text] [Related]
11. Stemness Marker Detection in the Periphery of Glioblastoma and Ability of Glioblastoma to Generate Glioma Stem Cells: Clinical Correlations.
Raysi Dehcordi S; Ricci A; Di Vitantonio H; De Paulis D; Luzzi S; Palumbo P; Cinque B; Tempesta D; Coletti G; Cipolloni G; Cifone MG; Galzio R
World Neurosurg; 2017 Sep; 105():895-905. PubMed ID: 28559081
[TBL] [Abstract][Full Text] [Related]
12. The Invasive Region of Glioblastoma Defined by 5ALA Guided Surgery Has an Altered Cancer Stem Cell Marker Profile Compared to Central Tumour.
Smith SJ; Diksin M; Chhaya S; Sairam S; Estevez-Cebrero MA; Rahman R
Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29156557
[TBL] [Abstract][Full Text] [Related]
13. Lineage-Restricted OLIG2-RTK Signaling Governs the Molecular Subtype of Glioma Stem-like Cells.
Kupp R; Shtayer L; Tien AC; Szeto E; Sanai N; Rowitch DH; Mehta S
Cell Rep; 2016 Sep; 16(11):2838-2845. PubMed ID: 27626655
[TBL] [Abstract][Full Text] [Related]
14. [Brain tumor stem cells].
Hide T; Makino K; Nakamura H; Yano S; Kuratsu J
Nihon Rinsho; 2015 May; 73(5):836-43. PubMed ID: 25985640
[TBL] [Abstract][Full Text] [Related]
15. Changes in chromatin state reveal ARNT2 at a node of a tumorigenic transcription factor signature driving glioblastoma cell aggressiveness.
Bogeas A; Morvan-Dubois G; El-Habr EA; Lejeune FX; Defrance M; Narayanan A; Kuranda K; Burel-Vandenbos F; Sayd S; Delaunay V; Dubois LG; Parrinello H; Rialle S; Fabrega S; Idbaih A; Haiech J; Bièche I; Virolle T; Goodhardt M; Chneiweiss H; Junier MP
Acta Neuropathol; 2018 Feb; 135(2):267-283. PubMed ID: 29149419
[TBL] [Abstract][Full Text] [Related]
16. Comparison of glioma stem cells to neural stem cells from the adult human brain identifies dysregulated Wnt- signaling and a fingerprint associated with clinical outcome.
Sandberg CJ; Altschuler G; Jeong J; Strømme KK; Stangeland B; Murrell W; Grasmo-Wendler UH; Myklebost O; Helseth E; Vik-Mo EO; Hide W; Langmoen IA
Exp Cell Res; 2013 Aug; 319(14):2230-43. PubMed ID: 23791939
[TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic characterization of human glioblastoma stem cells: correlation with clinical outcome.
Miconi G; Palumbo P; Dehcordi SR; La Torre C; Lombardi F; Evtoski Z; Cimini AM; Galzio R; Cifone MG; Cinque B
J Cell Biochem; 2015 May; 116(5):864-76. PubMed ID: 25559650
[TBL] [Abstract][Full Text] [Related]
18. Cell death and neuronal differentiation of glioblastoma stem-like cells induced by neurogenic transcription factors.
Guichet PO; Bieche I; Teigell M; Serguera C; Rothhut B; Rigau V; Scamps F; Ripoll C; Vacher S; Taviaux S; Chevassus H; Duffau H; Mallet J; Susini A; Joubert D; Bauchet L; Hugnot JP
Glia; 2013 Feb; 61(2):225-39. PubMed ID: 23047160
[TBL] [Abstract][Full Text] [Related]
19. Reconstructing and reprogramming the tumor-propagating potential of glioblastoma stem-like cells.
Suvà ML; Rheinbay E; Gillespie SM; Patel AP; Wakimoto H; Rabkin SD; Riggi N; Chi AS; Cahill DP; Nahed BV; Curry WT; Martuza RL; Rivera MN; Rossetti N; Kasif S; Beik S; Kadri S; Tirosh I; Wortman I; Shalek AK; Rozenblatt-Rosen O; Regev A; Louis DN; Bernstein BE
Cell; 2014 Apr; 157(3):580-94. PubMed ID: 24726434
[TBL] [Abstract][Full Text] [Related]
20. A novel gene signature based on five glioblastoma stem-like cell relevant genes predicts the survival of primary glioblastoma.
Chai R; Zhang K; Wang K; Li G; Huang R; Zhao Z; Liu Y; Chen J
J Cancer Res Clin Oncol; 2018 Mar; 144(3):439-447. PubMed ID: 29299749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
